Skip to main content
Cantargia logo

Cantargia — Investor Relations & Filings

Ticker · CANTA ISIN · SE0023312970 LEI · 549300GKWRT7RXI4VS85 ST Manufacturing
Open in API
Filings indexed 511 across all filing types
Latest filing 2019-01-23 Major Shareholding Noti…
Country SE Sweden
Listing ST CANTA

About Cantargia

https://cantargia.com/en/

Cantargia is a biotechnology company that develops antibody-based therapies targeting the interleukin-1 receptor accessory protein (IL1RAP). This protein is involved in signaling pathways that can drive cancer and inflammatory diseases. The company's lead asset, nadunolimab (CAN04), is a clinical-stage antibody under investigation for the treatment of various forms of cancer, including pancreatic cancer. Cantargia also developed the CAN10 program, an antibody targeting IL1RAP for autoimmune and inflammatory conditions, which was acquired by Otsuka Pharmaceutical.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding ('Reason for major shareholding notification Sell') where the resulting percentage of voting rights (4.981% and 4.9854% total) crosses a threshold ('Flaggning sker för passerat tröskelvärde'). This structure, involving reporting changes in significant ownership levels by a holder (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension), directly corresponds to the definition of a Major Shareholding Notification. The code for this is MRQ.
2019-01-23 English
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage by a specific holder (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension). It explicitly lists the 'Reason for major shareholding notification Sell', the 'Date' of the transaction (18/01/2019), and the resulting share quantities and percentages. This structure perfectly matches the definition of a Major Shareholding Notification, which is categorized under the code MRQ.
2019-01-21 English
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding, specifically reporting that Avanza Bank Holding AB now holds 3,311,629 shares, representing 5.004% of the voting rights, which crosses a notification threshold (5%). This structure, focusing on the quantity of shares held by an entity and the percentage of voting rights, is characteristic of a Major Shareholding Notification. The filing type code corresponding to this is MRQ (Major Shareholding Notification). The document is short and contains specific transactional data rather than a comprehensive report.
2019-01-15 English
Declaration of Voting Results & Voting Rights Announcements 2019
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document explicitly details a change in shareholding ('Reason for major shareholding notification Sell') by a specific holder ('Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension'). It reports the 'Before the transaction' and 'After the transaction' quantities and percentages, specifically noting that the resulting percentage is 4.996%, which is below the 5% limit mentioned. This structure perfectly matches the definition of a Major Shareholding Notification, which tracks when ownership crosses specified thresholds. The corresponding code is MRQ.
2019-01-14 English
Major Shareholding Notification 2019
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding where a holder, Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension, has crossed a threshold, resulting in a new holding percentage of 5.01%. The structure explicitly mentions 'Reason for major shareholding notification Buy' and provides detailed tables showing 'Before the transaction' and 'After the transaction' share quantities and voting rights percentages. This content directly corresponds to the definition of a Major Shareholding Notification.
2019-01-04 English
Cantargia presenterar nya positiva prekliniska data för antikroppen CAN04 på en större antikroppskonferens
Regulatory Filings Classification · 99% confidence The document is a press release dated December 10, 2018, announcing that new preclinical data for the antibody CAN04 will be presented at a scientific conference (Antibody Engineering and Therapeutics). It details scientific findings, ongoing clinical trials (CANFOUR), and mentions that the poster presentation will be available on the company website. Crucially, the final paragraph states: "Denna information är sådan som Cantargia AB är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning." (This information is such that Cantargia AB is obliged to make public according to the EU Market Abuse Regulation.) Since this is a general announcement about scientific data presentation and regulatory disclosure, and it is not a full financial report (10-K, IR), an earnings release (ER), or a specific proxy/dividend notice, it falls best under the general regulatory announcement category, which is RNS (Regulatory Filings). It is not an Investor Presentation (IP) because it is a press release *about* a presentation, not the presentation itself, and it is not an Earnings Release (ER) as it focuses on scientific data, not financial results.
2018-12-10 Swedish

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.